Is p-ANCA in ulcerative colitis directed against β-glucuronidase?
- 1 January 1993
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 341 (8840) , 320
- https://doi.org/10.1016/0140-6736(93)92686-n
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitisClinical and Experimental Immunology, 1992
- Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.Gut, 1992
- Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis.Gut, 1992
- Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitisGastroenterology, 1991
- A New Type of Perinuclear Anti-Neutrophil Cytoplasmic Antibody (p-ANCA) in Active Ulcerative Colitis but not in Crohn's DiseaseImmunobiology, 1990